Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.
Madic J, Kiialainen A, Bidard FC, Birzele F, Ramey G, Leroy Q, Rio Frio T, Vaucher I, Raynal V, Bernard V, Lermine A, Clausen I, Giroud N, Schmucki R, Milder M, Horn C, Spleiss O, Lantz O, Stern MH, Pierga JY, Weisser M, Lebofsky R. Madic J, et al. Among authors: birzele f. Int J Cancer. 2015 May 1;136(9):2158-65. doi: 10.1002/ijc.29265. Epub 2014 Oct 23. Int J Cancer. 2015. PMID: 25307450
MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemia.
Zhong H, Chen G, Jukofsky L, Geho D, Han SW, Birzele F, Bader S, Himmelein L, Cai J, Albertyn Z, Rothe M, Essioux L, Burtscher H, Middleton SA, Rueger R, Chen LC, Dangl M, Nichols G, Pierceall WE. Zhong H, et al. Among authors: birzele f. Br J Haematol. 2015 Nov;171(3):432-5. doi: 10.1111/bjh.13411. Epub 2015 Apr 8. Br J Haematol. 2015. PMID: 25855517 Free PMC article. Clinical Trial. No abstract available.
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies.
Denis M, Grasselly C, Choffour PA, Wierinckx A, Mathé D, Chettab K, Tourette A, Talhi N, Bourguignon A, Birzele F, Kress E, Jordheim LP, Klein C, Matera EL, Dumontet C. Denis M, et al. Among authors: birzele f. Cancer Immunol Res. 2022 Aug 3;10(8):1013-1027. doi: 10.1158/2326-6066.CIR-21-0802. Cancer Immunol Res. 2022. PMID: 35679518
59 results